Early-life exposures and the microbiome: implications for IBD prevention

Area of Science:

• Microbiome research
• Immunology
• Gastroenterology

Background:

• The early-life period is critical for gut microbiome establishment and immune system development.
• Early-life exposures significantly influence the risk of developing inflammatory bowel disease (IBD).
• Gut microbiome composition and function during prenatal, perinatal, and postnatal stages are key determinants of long-term health or disease, including IBD.

Purpose of the Study:

• To comprehensively summarize the interplay between early-life factors, microbiome alterations, and IBD risk.
• To review host and external factors impacting early gut microbiome maturation and IBD risk exposures.
• To propose strategies for IBD prevention by minimizing harmful exposures during pregnancy and postpartum.

Main Methods:

• Literature review and synthesis of existing research on early-life factors, microbiome, and IBD.
• Analysis of host and environmental influences on infant gut microbiome development.
• Identification of key exposures associated with IBD risk.

Main Results:

• Early-life exposures significantly shape the gut microbiome, influencing IBD susceptibility.
• Specific maternal and infant factors during pregnancy and postpartum are linked to altered microbiome profiles and disease risk.
• A holistic understanding of early-life microbiome signatures is emerging.

Conclusions:

• Early-life microbiome development is a critical window for IBD pathogenesis.
• Minimizing exposure to detrimental factors during pregnancy and postpartum is essential for IBD prevention.
• Future research should focus on developing targeted preventive strategies based on early-life microbiome insights.